• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于有效评估患者报告的身体不适的六项多发性硬化症影响量表简表(MSIS-SF)的验证

Validation of a Six-Item Multiple Sclerosis Impact Scale Short Form (MSIS-SF) for Efficient Assessment of Patient-Reported Physical Disturbance.

作者信息

Sumowski James F, Levy Sarah

机构信息

Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Department of Neurology, Icahn School of Medicine at Mount Sinai.

出版信息

medRxiv. 2025 Feb 7:2025.02.06.25321807. doi: 10.1101/2025.02.06.25321807.

DOI:10.1101/2025.02.06.25321807
PMID:39974136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11838650/
Abstract

Patient-reported outcomes importantly reflect the lived experiences of persons with multiple sclerosis (MS); however, given the broad array of MS symptoms, comprehensive evaluation can be burdensome, especially with lengthy questionnaires. The MS Impact Scale queries twenty different physical difficulties (MSIS-20). In 1150 patients with MS, evaluation of internal consistency indicated redundancy in the MSIS-20 (Cronbach's alpha: 0.96), but optimal internal consistency (0.90) of a six-item short form (MSIS-SF; first six MSIS items). The MSIS-20 and MSIS-SF showed comparably strong associations with objective physical disability. The MSIS-SF provides a psychometrically robust, less burdensome, and time-efficient option for assessing patient-reported physical disturbance.

摘要

患者报告的结果能重要地反映多发性硬化症(MS)患者的实际生活体验;然而,鉴于MS症状种类繁多,全面评估可能会很繁琐,尤其是使用冗长的问卷时。MS影响量表询问了20种不同的身体困难(MSIS - 20)。在1150例MS患者中,内部一致性评估表明MSIS - 20存在冗余(克朗巴赫α系数:0.96),而一个六项简短形式(MSIS - SF;MSIS的前六项)具有最佳的内部一致性(0.90)。MSIS - 20和MSIS - SF与客观身体残疾显示出相当强的关联。MSIS - SF为评估患者报告的身体不适提供了一种心理测量稳健、负担较小且省时的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd0/11838650/5cd721560493/nihpp-2025.02.06.25321807v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd0/11838650/3426b4e4d03f/nihpp-2025.02.06.25321807v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd0/11838650/5cd721560493/nihpp-2025.02.06.25321807v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd0/11838650/3426b4e4d03f/nihpp-2025.02.06.25321807v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd0/11838650/5cd721560493/nihpp-2025.02.06.25321807v1-f0002.jpg

相似文献

1
Validation of a Six-Item Multiple Sclerosis Impact Scale Short Form (MSIS-SF) for Efficient Assessment of Patient-Reported Physical Disturbance.用于有效评估患者报告的身体不适的六项多发性硬化症影响量表简表(MSIS-SF)的验证
medRxiv. 2025 Feb 7:2025.02.06.25321807. doi: 10.1101/2025.02.06.25321807.
2
Cross-cultural adaptation and validation of the Arabic version of the Multiple Sclerosis Impact Scale-29.《多发性硬化症影响量表29项阿拉伯语版本的跨文化适应与验证》
Disabil Rehabil. 2025 Jan;47(2):485-492. doi: 10.1080/09638288.2024.2350618. Epub 2024 May 13.
3
The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure.多发性硬化症影响量表(MSIS - 29):一种基于患者的新型结局指标。
Brain. 2001 May;124(Pt 5):962-73. doi: 10.1093/brain/124.5.962.
4
Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome.改善多发性硬化症治疗干预措施的评估:基于患者的结局指标的开发。
Health Technol Assess. 2004 Mar;8(9):iii, 1-48. doi: 10.3310/hta8090.
5
Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.使用多发性硬化症影响量表来估算健康状态效用值:从 MSIS-29 版本 2 到 EQ-5D 和 SF-6D 的映射。
Value Health. 2012 Dec;15(8):1084-91. doi: 10.1016/j.jval.2012.07.007. Epub 2012 Nov 4.
6
Validation of the Arabic Version of the Multiple Sclerosis Impact Scale (MSIS-29): a Rasch Analysis Study.多发性硬化症影响量表阿拉伯语版(MSIS - 29)的验证:一项拉施分析研究。
Arch Clin Neuropsychol. 2025 Apr 27;40(3):520-528. doi: 10.1093/arclin/acae121.
7
Patient reported outcomes in a secondary progressive MS cohort related to cognition, MRI and physical outcomes.在一个与认知、磁共振成像(MRI)及身体状况相关的继发进展型多发性硬化症队列中患者报告的结果。
Mult Scler Relat Disord. 2023 Mar;71:104550. doi: 10.1016/j.msard.2023.104550. Epub 2023 Feb 5.
8
Rasch analysis of the Multiple Sclerosis Impact Scale MSIS-29.多发性硬化症影响量表MSIS - 29的拉施分析。
Health Qual Life Outcomes. 2009 Jun 22;7:58. doi: 10.1186/1477-7525-7-58.
9
Psychometric properties of the Croatian version of the depression, anxiety, and stress scale-21 and multiple sclerosis impact scale-29 in multiple sclerosis patients.克罗地亚语版抑郁、焦虑和压力量表-21以及多发性硬化症影响量表-29在多发性硬化症患者中的心理测量特性。
Mult Scler Relat Disord. 2021 May;50:102850. doi: 10.1016/j.msard.2021.102850. Epub 2021 Feb 20.
10
Does the Multiple Sclerosis Impact Scale-29 (MSIS-29) have the range to capture the experience of fully ambulatory multiple sclerosis patients? Learnings from the ASCLEPIOS studies.多发性硬化症影响量表-29(MSIS-29)是否能够涵盖完全可独立行走的多发性硬化症患者的体验?来自ASCLEPIOS研究的经验教训。
Mult Scler J Exp Transl Clin. 2023 Sep 28;9(3):20552173231201422. doi: 10.1177/20552173231201422. eCollection 2023 Jul-Sep.

本文引用的文献

1
Multiple Sclerosis Cognitive Scale (MSCS): A brief psychometrically robust metric of patient-reported cognitive difficulty.多发性硬化症认知量表(MSCS):一种经心理测量学验证的、用于评估患者自述认知困难的简短指标。
Mult Scler. 2025 Mar;31(3):352-362. doi: 10.1177/13524585241309805. Epub 2025 Feb 2.
2
Detection of subtle gait disturbance and future fall risk in early multiple sclerosis.早期多发性硬化症中微妙步态障碍的检测与未来跌倒风险。
Neurology. 2020 Mar 31;94(13):e1395-e1406. doi: 10.1212/WNL.0000000000008938. Epub 2020 Feb 26.
3
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis.
25英尺定时步行作为多发性硬化症动态表现结果测量指标的有效性。
Mult Scler. 2017 Apr;23(5):704-710. doi: 10.1177/1352458517690823. Epub 2017 Feb 16.
4
The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis.九孔插板测试作为多发性硬化症手部灵巧性的一项性能指标。
Mult Scler. 2017 Apr;23(5):711-720. doi: 10.1177/1352458517690824. Epub 2017 Feb 16.
5
Patient-reported outcomes: A new era in clinical research.患者报告的结局:临床研究的新时代。
Perspect Clin Res. 2011 Oct;2(4):137-44. doi: 10.4103/2229-3485.86879.
6
Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.多发性硬化症功能综合量表的心理测量学和常模数据:用符号数字模态测试替代 PASAT。
Mult Scler. 2010 Feb;16(2):228-37. doi: 10.1177/1352458509354552. Epub 2009 Dec 22.
7
Rasch analysis of the Fatigue Severity Scale in multiple sclerosis.多发性硬化症疲劳严重程度量表的拉施分析。
Mult Scler. 2009 Jan;15(1):81-7. doi: 10.1177/1352458508096215. Epub 2008 Aug 28.
8
Starting at the beginning: an introduction to coefficient alpha and internal consistency.从头开始:系数α与内部一致性介绍
J Pers Assess. 2003 Feb;80(1):99-103. doi: 10.1207/S15327752JPA8001_18.
9
The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure.多发性硬化症影响量表(MSIS - 29):一种基于患者的新型结局指标。
Brain. 2001 May;124(Pt 5):962-73. doi: 10.1093/brain/124.5.962.
10
Development of a multiple sclerosis functional composite as a clinical trial outcome measure.开发一种多发性硬化功能综合指标作为临床试验结果测量指标。
Brain. 1999 May;122 ( Pt 5):871-82. doi: 10.1093/brain/122.5.871.